ERIC GOLDBERG: Open Payments
NPI 1679524946 · DESTIN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$118,233 in 227 payments from 16 companies in 2025. Trend: 2023 $39,164 · 2024 $36,998 · 2025 $118,233
Speaker / faculty: $64,680Honoraria: $31,175Travel & lodging: $11,110Food & beverage: $5,989Consulting: $5,280
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 155 | $80,831 |
| Supernus Pharmaceuticals, Inc. | 32 | $33,548 |
| MDD US Operations, LLC | 4 | $2,693 |
| ABBVIE INC. | 9 | $253 |
| Vanda Pharmaceuticals Inc. | 4 | $151 |
| Boston Scientific Corporation | 1 | $150 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| JAZZ PHARMACEUTICALS INC. | 4 | $119 |
| Lundbeck LLC | 2 | $41 |
Products named: CAPLYTA, Qelbree, VRAYLAR, FANAPT, WATCHMAN FLX, Auvelity, TEZSPIRE, XYWAV.
Industry payments across FL — which companies pay providers there.
